<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chan JF</submitter><funding>NCI NIH HHS</funding><pagination>eadd3867</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9858505</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(3)</volume><pubmed_abstract>Successful severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires proteolytic cleavage of the viral spike protein. While the role of the host transmembrane protease serine 2 in SARS-CoV-2 infection is widely recognized, the involvement of other proteases capable of facilitating SARS-CoV-2 entry remains incompletely explored. Here, we show that multiple members from the membrane-type matrix metalloproteinase (MT-MMP) and a disintegrin and metalloproteinase families can mediate SARS-CoV-2 entry. Inhibition of MT-MMPs significantly reduces SARS-CoV-2 replication in vitro and in vivo. Mechanistically, we show that MT-MMPs can cleave SARS-CoV-2 spike and angiotensin-converting enzyme 2 and facilitate spike-mediated fusion. We further demonstrate that Omicron BA.1 has an increased efficiency on MT-MMP usage, while an altered efficiency on transmembrane serine protease usage for virus entry compared with that of ancestral SARS-CoV-2. These results reveal additional protease determinants for SARS-CoV-2 infection and enhance our understanding on the biology of coronavirus entry.</pubmed_abstract><journal>Science advances</journal><pubmed_title>Altered host protease determinants for SARS-CoV-2 Omicron.</pubmed_title><pmcid>PMC9858505</pmcid><funding_grant_id>P30 CA008748</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Cai JP</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Chan JF</pubmed_authors><pubmed_authors>Yuen TT</pubmed_authors><pubmed_authors>Zhang AJ</pubmed_authors><pubmed_authors>Shuai H</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Shi ZL</pubmed_authors><pubmed_authors>Yin F</pubmed_authors><pubmed_authors>Wen L</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Yoon C</pubmed_authors><pubmed_authors>Zhang BZ</pubmed_authors><pubmed_authors>Chu H</pubmed_authors><pubmed_authors>Yuen KY</pubmed_authors><pubmed_authors>Shi J</pubmed_authors><pubmed_authors>Chai Y</pubmed_authors><pubmed_authors>Brindley MA</pubmed_authors><pubmed_authors>Shi H</pubmed_authors><pubmed_authors>Zhu T</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Altered host protease determinants for SARS-CoV-2 Omicron.</name><description>Successful severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires proteolytic cleavage of the viral spike protein. While the role of the host transmembrane protease serine 2 in SARS-CoV-2 infection is widely recognized, the involvement of other proteases capable of facilitating SARS-CoV-2 entry remains incompletely explored. Here, we show that multiple members from the membrane-type matrix metalloproteinase (MT-MMP) and a disintegrin and metalloproteinase families can mediate SARS-CoV-2 entry. Inhibition of MT-MMPs significantly reduces SARS-CoV-2 replication in vitro and in vivo. Mechanistically, we show that MT-MMPs can cleave SARS-CoV-2 spike and angiotensin-converting enzyme 2 and facilitate spike-mediated fusion. We further demonstrate that Omicron BA.1 has an increased efficiency on MT-MMP usage, while an altered efficiency on transmembrane serine protease usage for virus entry compared with that of ancestral SARS-CoV-2. These results reveal additional protease determinants for SARS-CoV-2 infection and enhance our understanding on the biology of coronavirus entry.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-02T11:14:51.113Z</modification><creation>2025-02-18T23:26:12.806Z</creation></dates><accession>S-EPMC9858505</accession><cross_references><pubmed>36662861</pubmed><doi>10.1126/sciadv.add3867</doi></cross_references></HashMap>